These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12947081)
1. Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence. van Dalen EC; van der Pal HJ; van den Bos C; Caron HN; Kremer LC J Clin Oncol; 2003 Sep; 21(17):3377; author reply 3377-8. PubMed ID: 12947081 [No Abstract] [Full Text] [Related]
2. Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Scully RE; Lipshultz SE Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816 [TBL] [Abstract][Full Text] [Related]
3. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors. Andolina JR; Dilley K J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481 [TBL] [Abstract][Full Text] [Related]
4. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. van Dalen EC; van den Brug M; Caron HN; Kremer LC Eur J Cancer; 2006 Dec; 42(18):3199-205. PubMed ID: 17011186 [TBL] [Abstract][Full Text] [Related]
5. Anthracycline associated cardiac toxicity in children with malignancies. Mohta R; Saxena A; Jain Y; Gupta S; Thavaraj V; Narain S; Arya LS Indian Pediatr; 2002 Jun; 39(6):549-55. PubMed ID: 12084948 [No Abstract] [Full Text] [Related]
6. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer. Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913 [TBL] [Abstract][Full Text] [Related]
7. A drug for prevention of anthracycline-induced cardiac toxicity. Med Lett Drugs Ther; 1991 Sep; 33(852):85-6. PubMed ID: 1908544 [No Abstract] [Full Text] [Related]
8. [Cardiologic sequelae of cytostatic therapy]. Mladosievivcová B Cas Lek Cesk; 2001 Mar; 140(5):138-41. PubMed ID: 11347200 [TBL] [Abstract][Full Text] [Related]
9. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines. Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569 [TBL] [Abstract][Full Text] [Related]
10. Childhood cancer, anthracyclines, and the heart. Lancet; 1992 Jun; 339(8806):1388-9. PubMed ID: 1350811 [No Abstract] [Full Text] [Related]
11. Monitoring of anthracycline-induced cardiotoxicity. Jannazzo A; Hoffman J; Lutz M Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345 [TBL] [Abstract][Full Text] [Related]
12. Genotyping the risk of anthracycline-induced cardiotoxicity. Deng S; Wojnowski L Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817 [TBL] [Abstract][Full Text] [Related]